The Pharmaceutical Market: Peru (pdf/xls)

The Pharmaceutical Market: Peru (pdf/xls)


February 17, 2012
58 Pages - SKU: ESPI3804770
License type:
Online Download      US $1,085.00
Global Site License      US $7,095.00
Countries covered: Peru

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
  • The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.


Additional Information

THE PHARMACEUTICAL MARKET: PERU - REVIEW

The Peruvian pharmaceutical market is the second smallest in the region. The market is expected to increase by a moderate CAGR in dollar terms between 2011 and 2016. Pharmaceutical expenditure per capita is the lowest in the region. This means that there are growth opportunities, as the economy is expected to perform well in the forecast period. The market increased five times between 1995 and 2010. In January 2011, the Israeli company Teva Pharmaceutical Industries announced that it was acquiring Infarmasa from The Rohatyn Group (TRG) and Altra Investments. Teva commented that the combination of Medco, which is Teva’s existing operation in Peru, and Infarmasa would create one of the top two pharmaceutical companies in the country.

Peru is often overlooked when discussing the rapid-growth economies of South America. While it has neither the size nor the wealth of Brazil or Argentina, the country has a population that exceeds 30 million in 2011, and has recorded strong economic growth in recent years. According to the Economist Intelligence Unit (EIU), GDP growth increased by 6.5% in real terms in 2011. GDP per capita wealth has risen, especially around Lima, leading to a sizeable urban population that demands improved healthcare and has the ability to pay for it. This economic environment is expected to encourage drug consumption. In legal terms, Peru is continuing to implement its National Strategic Plan to combat counterfeiting and piracy.

Major Peruvian pharmaceutical wholesalers include Química Suiza, Albis and Drokasa. Química Suiza imports, produces, markets and distributes pharmaceuticals, personal care products and equipment for the industrial sector. The company has offices in Arequipa, Chiclayo, Cusco, Huancayo, Iquitos, Lima, Piura and Trujillo. Química Suiza also has a regional presence with subsidiaries in Bolivia, Colombia, Ecuador and Venezuela. The company has six divisions. In February 2011, Química Suiza acquired the pharmacy chain Boticas BTL for an undisclosed transaction value. With this acquisition, Química Suiza will control about 300 pharmacies in Peru; the company already owns Boticas Mifarma in the retail pharmacy sector.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

More Prescription Drugs reports by Espicom Healthcare Intelligence

Inhalation & Nasal Spray Generic Drugs 2013 by Espicom Healthcare Intelligence
Inhalation & Nasal Spray Generic Drugs 2013 Around three quarters of the US$36.4 billion respiratory prescription drugs market comprises drugs that are delivered using inhalation ...
Middle East North Africa Pharmaceutical Market Forecasts to 2018 by Espicom Healthcare Intelligence
Middle East North Africa Pharmaceutical Market Forecasts to 2018 The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but ...
The World Prescription Drug Market Report by Espicom Healthcare Intelligence
The World Prescription Drug Market ReportKey Market Questions Answered by The World Prescription Drug Market Report: Which country has the highest prescription drug expenditure? Which ...
The World Pharmaceutical Markets Fact Book 2013 by Espicom Healthcare Intelligence
The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ...
See all reports like this >>

More Peru Prescription Drugs reports

Peru Pharmaceuticals and Healthcare Report Q2 2014 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2014BMI View: Peru will offer longer-term growth opportunities to foreign pharmaceutical companies.Although per capita medicine spending in the country ...
Peru Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: We continue to view Peru as a moderately attractive pharmaceutical market, on account ofelevated risks posed by regulatory and intellectual property (IP) shortcomings ...
Antibiotics Market in Peru to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Peru. The study provides essential market ...
Peru Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: Based on new historical data for Peru's pharmaceutical sales in 2010 and 2011, we have reevaluated our forecasts for the country. The total ...
See all reports like this >>

More Peru reports

D&B Country RiskLine Report: Peru by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Australian Cloud Computing Research Program 2011: A Strategic Analysis of the Australian Data Centre Infrastructure and Services Market by Frost & Sullivan
This report analyses end-user perception, adoption and usage of data centre infrastructure and services in Australia. Through detailed end-user interviews, the Australian data centre infrastructure ...
D&B Country Report: Peru by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>